Abraham Silji's most recent trade in West Pharmaceutical Services, Inc. was a trade of 458 Common Stock done . Disclosure was reported to the exchange on Oct. 29, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| West Pharma Services | Silji Abraham | SVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2024 | 458 | 3,318 (0%) | 0% | 0 | Common Stock | |
| West Pharma Services | Silji Abraham | SVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2024 | 458 | 0 | - | - | Rst. Stock Unit | |
| West Pharma Services | Silji Abraham | SVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 318.82 per share. | 29 Oct 2024 | 180 | 3,138 (0%) | 0% | 318.8 | 57,388 | Common Stock |
| West Pharma Services | Silji Abraham | SVP, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 330.78 per share. | 12 Jun 2024 | 1,800 | 2,860 (0%) | 0% | 330.8 | 595,404 | Common Stock |
| West Pharma Services | Abraham Silji | SVP, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 365.00 per share. | 23 Feb 2024 | 7,012 | 4,660 (0%) | 0% | 365 | 2,559,380 | Common Stock |
| West Pharma Services | Silji Abraham | SVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 7,012 | 0 | - | - | Stock Options (Right to Buy) | |
| West Pharma Services | Abraham Silji | SVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 173.22 per share. | 23 Feb 2024 | 7,012 | 11,672 (0%) | 0% | 173.2 | 1,214,619 | Common Stock |
| West Pharma Services | Silji Abraham | SVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 2,968 | 2,968 | - | - | Stock Options (Right to Buy) | |
| West Pharma Services | Abraham Silji | SVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 646 | 4,660 (0%) | 0% | 0 | Common Stock | |
| West Pharma Services | Silji Abraham | SVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 102.51 per share. | 08 Aug 2023 | 8,160 | 12,369 (0%) | 0% | 102.5 | 836,482 | Common Stock |
| West Pharma Services | Silji Abraham | SVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2023 | 8,160 | 0 | - | - | Stock Options (Right to buy) | |
| West Pharma Services | Silji Abraham | SVP, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 397.18 per share. | 08 Aug 2023 | 8,154 | 4,215 (0%) | 0% | 397.2 | 3,238,586 | Common Stock |
| West Pharma Services | Silji Abraham | SVP, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 397.67 per share. | 08 Aug 2023 | 6 | 4,209 (0%) | 0% | 397.7 | 2,386 | Common Stock |
| West Pharma Services | Silji Abraham | SVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 86.24 per share. | 01 May 2023 | 8,020 | 12,229 (0%) | 0% | 86.2 | 691,645 | Common Stock |
| West Pharma Services | Silji Abraham | SVP, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 8,020 | 0 | - | - | Stock Options (Right to Buy) | |
| West Pharma Services | Silji Abraham | SVP, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 365.55 per share. | 01 May 2023 | 7,371 | 4,858 (0%) | 0% | 365.6 | 2,694,493 | Common Stock |
| West Pharma Services | Silji Abraham | SVP, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 366.14 per share. | 01 May 2023 | 649 | 4,209 (0%) | 0% | 366.1 | 237,624 | Common Stock |
| West Pharma Services | Silji Abraham | SVP, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 322.57 per share. | 01 Mar 2023 | 1,500 | 4,209 (0%) | 0% | 322.6 | 483,850 | Common Stock |
| West Pharma Services | Silji Abraham | SVP, Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 318.28 per share. | 01 Mar 2023 | 234 | 5,709 (0%) | 0% | 318.3 | 74,478 | Common Stock |
| West Pharma Services | Silji Abraham | Chief Digital & Trans Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 3,216 | 3,216 | - | - | Stock Options (Right to buy) | |
| West Pharma Services | Silji Abraham | Chief Digital & Trans Officer | Grant, award, or other acquisition of securities at price $ 306.68 per share. | 21 Feb 2023 | 2,274 | 5,475 (0%) | 0% | 306.7 | 697,390 | Common Stock |
| West Pharma Services | Silji Abraham | Chief Digital & Trans Officer | Sale of securities on an exchange or to another person at price $ 343.93 per share. | 01 Aug 2022 | 5,374 | 3,201 (0%) | 0% | 343.9 | 1,848,306 | Common Stock |
| West Pharma Services | Silji Abraham | Chief Digital & Trans Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 3,108 | 3,108 | - | - | Stock Options (Right to buy) | |
| West Pharma Services | Silji Abraham | Chief Digital & Trans Officer | Grant, award, or other acquisition of securities at price $ 369.13 per share. | 22 Feb 2022 | 2,498 | 8,575 (0%) | 0% | 369.1 | 922,087 | Common Stock |
| West Pharma Services | Silji Abraham | Chief Digital & Trans Officer | Sale of securities on an exchange or to another person at price $ 335.00 per share. | 10 May 2021 | 2,171 | 6,077 (0%) | 0% | 335 | 727,285 | Common Stock |
| West Pharma Services | Silji Abraham | Chief Digital & Trans Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 280.65 per share. | 26 Feb 2021 | 677 | 8,248 (0%) | 0% | 280.6 | 190,000 | Common Stock |
| West Pharma Services | Silji Abraham | Chief Digital & Trans Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2021 | 4,364 | 4,364 | - | - | Stock Options (Right to buy) | |
| West Pharma Services | Silji Abraham | Chief Digital & Trans Officer | Grant, award, or other acquisition of securities at price $ 272.65 per share. | 22 Feb 2021 | 2,577 | 8,925 (0%) | 0% | 272.6 | 702,619 | Common Stock |
| West Pharma Services | Silji Abraham | Chief Digital & Trans Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2020 | 1,956 | 1,956 | - | - | Stock Options (Right to Buy) | |
| West Pharma Services | Silji Abraham | Chief Digital & Trans Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2020 | 454 | 6,348 (0%) | 0% | 0 | Common Stock |